---
category: news
title: "Artificial Intelligence in Life Sciences #8"
excerpt: "This week was full of activity in the segment of pharmaceutical Artificial Intelligence (AI), let’s review some of the top developments:  RedCloud Bio Announces FDA Acceptance Of IND Application For Next-Generation Egfr Inhibitor H002 In Non-Small Cell Lung Cancer Shanghai-based RedCloud Bio,"
publishedDateTime: 2022-03-05T11:07:00Z
originalUrl: "https://www.linkedin.com/pulse/artificial-intelligence-life-sciences-8-andrii-buvailo-"
webUrl: "https://www.linkedin.com/pulse/artificial-intelligence-life-sciences-8-andrii-buvailo-"
type: article
quality: 37
heat: 37
published: false

provider:
  name: LinkedIn
  domain: linkedin.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/linkedin.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI

images:
  - url: "https://media-exp1.licdn.com/dms/image/C4E12AQHgn2eXidmgJA/article-cover_image-shrink_720_1280/0/1646419099759?e=1652313600&v=beta&t=CWvdHMdjqEazmK3dYCL7zH-k1PuDKy3XJE8iDU7VmYU"
    width: 1119
    height: 720
    isCached: true

secured: "zjF4ObG5h1S3uddcy9iWpe+a7chuKPaucJ4hlG8ZsYwYPI042tGNuZdtREe8k6s+6vNx9fmpRUtuhHk5y1kPtH2Kc0d9vmBvQ07K45PfAZPdfvEzyBAjcUhO9IaMs18cft1OBaaefS9K0l7cijG7vWUpzIkHTIijThKzHJtBkKjO0QpbIhpLv//uwnJWaomE79yLRceZ5mZ+2SrkGog8Yf73LMycHs5mSScO5H6w3JFcUkzFHsAhUi/Ce/NYfQTkoT8ZlTBXxF0tkdyIOoddgGL/mXfIWtcQ9H4gSebQZZJoGiwnGljsl20RuOodqIR65F2TpTysuF98e+EumlodWOOFgcXD9CfxJO7ycsj/vJ4=;q1OvianH73gq+SCAVRFdaw=="
---

